http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-094693-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8fae6bbf787fd922a88c105501e656f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
filingDate 2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac4362eb3f98bff597074651e0340c7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_552aa5821343ffacf19feaf9ccb7a176
publicationDate 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-094693-A1
titleOfInvention CHEMICAL COMPOSITIONS AND METHODS TO IMPROVE THE TRANSDERMAL SUPPLY OF THERAPEUTIC AGENTS
abstract Chemical compositions and methods to improve transdermal penetration of therapeutic agents through the skin. Chemical compositions and methods may include combinations of a first fatty acid having about 14 or more carbon atoms and a second fatty acid having about 10 or less carbon atoms. These compositions are useful for the delivery of therapeutic agents, in particular difficult to deliver drugs, such as those having fused rings, including ondansetron, and large drugs such as peptides. These compositions may be formulated as transdermal gels, lotions, creams, transdermal patches, sprays or mists. Claim 1: A composition, characterized in that it comprises: a first fatty acid that is oleic acid, linolenic acid, linoleic acid, mystolic acid, palmitoleic acid, or erucic acid, or a derivative or congener thereof; and a second fatty acid that is 2-hydroxyoctanoic acid, 4-oxopentanoic acid, propionic acid, valeric acid, peruvian acid, acetoacetic acid, alanine, aspartic acid, asparagine, glutamic acid, glycine, licin, valine, or levulinic acid, or a derivative or congener of these. Claim 10: The composition of any one of claims 7 to 9, characterized in that the therapeutic agent is one or more of: ondansetron, dolasetron, granisetron, tropisetron, palonosetron, or salts thereof. Claim 21: The use of the composition according to any of claims 6 to 20 for the manufacture of a medicament for treating a disease or condition. Claim 34: A method of forming a composition, characterized in that it comprises mixing a first fatty acid that is oleic acid, linolenic acid, linoleic acid, myristoleic acid, palmitoleic acid, or erucic acid, or a derivative or congener thereof; with a second fatty acid that is 2-hydroxyoctanoic acid, 4-oxopentanoic acid, propionic acid, valeric acid, peruvian acid, acetoacetic acid, alanine, aspartic acid, asparagine, glutamic acid, glycine, licin, valine, or levulinic acid, or a derivative or congener of these; and a therapeutic agent.
priorityDate 2012-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408335764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426285888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421226982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6337614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID96
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409736587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408376618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425739715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474480
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456126543

Total number of triples: 79.